Fed. Circuit upholds decision canceling claims in Durezol eyedrops patent [Reuters]
AKORN (AKRX)
Last akorn earnings: 10/31 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.akorn.com
Company Research
Source: Reuters
Fed. Circuit upholds decision canceling claims in Durezol eyedrops patent | Reuters 1 Min Read A federal appeals court on Wednesday upheld a ruling that invalidated a patent covering Novartis AG’s Durezol, opening the door for Akorn Inc to launch a generic version of the eye medication. The U.S. Court of Appeals for the Federal Circuit affirmed a determination by the Patent Trial and Appeal Board that most claims in the patent, exclusively licensed to Novartis by co-owners Senju Pharmaceutical Co Ltd and Mitsubishi Chemical Holdings Corporation, were invalid as obvious. To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2vOdWmF All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. Fed. Circuit upholds decision canceling claims in Durezol eyedrops patent A federal appeals court on Wednesday upheld a ruling that invalidated a patent covering Novartis AG’s Durezol, open
Show less
Read more
Impact Snapshot
Event Time:
AKRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKRX alerts
High impacting AKORN news events
Weekly update
A roundup of the hottest topics